AutoICD API

R89.7

Billable

Abnormal histolog findings in specimens from oth org/tiss

Abnormal histological findings in specimens from other organs, systems and tissues

Status

Billable / Specific

Block

R83-R89

Parent Code

R89

ICD-11 Mapping

1 equivalent

Coding Notes

Includes

Conditions included under this code

  • abnormal findings in nipple discharge
  • abnormal findings in synovial fluid
  • abnormal findings in wound secretions

Excludes 1

Codes that cannot be used together with this code (mutual exclusion)

Related Codes(9)
ICD-11 Equivalents(1)
Also Known As / Clinical Terms(576)

SNOMED CT

Clinical Terms

  • Surgical deep margin involved by tumor, multifocal
  • Surgical bladder neck margin involved by malignant neoplasm
  • Surgical lateral margin involved by malignant melanoma
  • Pleura, great vessels surgical margin, involved by tumor
  • Renal capsular surgical margin involved by malignant neoplasm
  • Surgical margin of renal vessel involved by tumor
  • Right parametrial surgical margin, involved by tumour
  • Surgical inferior margin involved by malignant neoplasm
  • Kidney, ureteral surgical margin, involved by tumour
  • Urinary bladder surgical margin, involved by tumor
  • Surgical deep margin involved by malignant neoplasm, multifocal
  • Surgical margin of optic nerve involved by tumour
  • Surgical inferior margin involved by ductal carcinoma in situ
  • Deep surgical margin involved by malignant neoplasm, focal
  • Greater than 10 mitoses per 10 HPF (score = 3)
  • Less than 10 mitoses per 10 HPF (score = 1)
  • Right lateral surgical margin involved by tumor
  • Surgical margin involved by DCIS
  • Right lateral surgical margin involved by tumour
  • Gerota fascial surgical margin, involved by tumour
  • Surgical renal capsular margin involved by tumour
  • Artefact due to smearing
  • Surgical deep margin involved by intraepithelial neoplasia
  • Deep surgical margin, focal, involvement by tumor present
  • Surgical omental margin finding
  • Breast surgical margin involved by tumor
  • Ureter, renal pelvis surgical margin, involved by tumor
  • Kidney, ureteral surgical margin, involved by tumor
  • Less than 10 mitoses per 10 high power fields (score = 1)
  • Surgical margin involved by intraepithelial neoplasia
  • Renal capsular surgical margin, involved by tumour
  • Muscularis propria absent in specimen
  • Renal vessel surgical margin, involved by tumor
  • Surgical Gerota fascial margin involved by malignant neoplasm
  • Deep surgical margin involved by malignant neoplasm
  • Deep surgical margin involvement by tumour present
  • Surgical renal capsular margin involved by tumor
  • Heart surgical margin, involved by tumor
  • Surgical deep margin involved by tumour
  • Left parametrial surgical margin, involved by tumour
  • Proximal ureteral surgical margin, involved by tumor
  • Surgical circumferential margin finding
  • Surgical greater omental margin involved by malignant neoplasm
  • Urinary bladder, vaginal surgical margin, involved by tumor
  • Breast tubule formation, moderate 10 percent to 75 percent (score = 2)
  • 0-5 mitoses per 10 high power fields (score = 1)
  • Surgical lateral margin involved by in situ melanoma
  • Surgical margin involvement by tumor present (breast)
  • Specimen involvement by matted nodes present
  • Surgical lateral (mucosal/mural) margin involved by adenoma
  • Breast tubule formation: Majority of tumour >75% (score = 1)
  • Greater than 20 mitoses per 10 high power fields (score = 3)
  • Less than 1 mitotic figure per mm2
  • Deep surgical margin involved by malignant neoplasm, multifocal
  • Surgical inferior margin is closest uninvolved margin to malignant neoplasm
  • Colon/rectum, deep (radial) surgical margin involved by tumor
  • 10 or more mitotic figures per 10 HPF
  • Renal pelvis surgical margin, involved by tumour
  • Specimen shows excessive cytolysis
  • Inferior lateral surgical margin, involvement by tumour present
  • Inferior lateral surgical margin involvement by tumor present
  • >20 mitoses per 10 HPF (score = 3)
  • Lateral surgical margin involvement by tumor present
  • Surgical lateral (mucosal/mural) margin involved by in situ carcinoma
  • Artefact due to freezing
  • Surgical medial margin involved by malignant neoplasm
  • Surgical proximal bile duct margin involved by malignant neoplasm
  • Urinary bladder, urethral surgical margin, involved by tumour
  • 0-5 mitoses per 10 HPF (score = 1)
  • Renal capsule surgical margin involved by tumor
  • Right lateral surgical margin, involved by tumour
  • Surgical renal vein margin involved by malignant neoplasm
  • Surgical parenchymal margin finding
  • Surgical apical margin involved by malignant neoplasm
  • Surgical circumferential margin involved by malignant neoplasm (tumor present 0-1 mm from circumferential resection margin)
  • Surgical renal parenchymal margin involved by malignant neoplasm
  • Small vessel invasion by tumor present
  • Surgical vascular margin involved by malignant neoplasm
  • Surgical deep margin involved by tumour, focal
  • Surgical lateral margin involved by tumor
  • Deep radial periureteral soft tissue surgical margin, involved by tumour
  • Breast tubule formation, minimal less than 10 percent (score = 3)
  • Left lateral surgical margin, involvement by tumour present
  • Urinary bladder, urachal surgical margin, involved by tumour
  • Surgical pancreatic duct margin involved by in situ carcinoma
  • Ureteral surgical margin, involved by tumor
  • Proximal ureteral surgical margin, involved by tumour
  • Abnormal histology findings
  • Surgical margin involved by malignant neoplasm, extensive
  • Surgical renal capsular margin involved by malignant neoplasm
  • Specimen obscured by mucus
  • Surgical chest wall margin involved by malignant neoplasm
  • Right parametrial surgical margin, involved by tumor
  • Breast tubule formation: Minimal <10% (score = 3)
  • Surgical margin involved by in situ carcinoma
  • Surgical margin involved by sarcoma
  • Urinary bladder, ureteral surgical margin, involved by tumour
  • Superior lateral surgical margin involved by tumor
  • Surgical margin of optic nerve involved by tumor
  • Deep radial periureteral soft tissue surgical margin, involved by tumor
  • Surgical deep margin involved by tumour, multifocal
  • Surgical medial margin involved by ductal carcinoma in situ
  • Mucosal surgical margin involved by malignant neoplasm
  • Surgical perinephric fat margin involved by malignant neoplasm
  • 10 or more mitotic figures per 10 high power field
  • Breast tubule formation, majority of tumor greater than 75 percent (score = 1)
  • Gerota's fascial surgical margin, involved by tumor
  • Greater than 20 mitoses per 10 HPF (score = 3)
  • Histology abnormal
  • 6-10 mitoses per 10 high power fields
  • Breast tubule formation finding
  • Morphologic artifact
  • Surgical Gerota's fascial margin involved by tumor
  • Surgical lateral (mucosal/mural) margin involved by malignant neoplasm
  • Treponema pallidum ELISA positive
  • Artefact due to crushing
  • Surgical Gerota's fascial margin involved by tumour
  • Surgical margin involvement by sarcoma cannot be assessed
  • Microcalcifications present in specimen (breast)
  • Surgical distal margin involved by tumour
  • Renal vessel surgical margin, involved by tumour
  • Surgical margin involved by ductal carcinoma in situ
  • Deep surgical margin, focal, involvement by tumour present
  • Surgical mucosal margin involved by adenoma
  • Surgical distal margin involved by malignant neoplasm
  • Surgical distal bile duct margin involved by malignant neoplasm
  • Breast tubule formation: Moderate 10% to 75% (score = 2)
  • Deep (radial) surgical margin involvement by tumor present (colon/rectum)
  • Specimen obscured by inflammation
  • Benign glands at surgical margin
  • Surgical deep margin involved by malignant neoplasm
  • Surgical deep margin involved by ductal carcinoma in situ
  • 6-10 mitoses per 10 high power fields (score = 2)
  • Urinary bladder, deep radial surgical margin, involved by tumour
  • Specimen involvement by satellite nodule(s) absent
  • Surgical bile duct margin involved by malignant neoplasm
  • Deep surgical margin involved by in situ carcinoma
  • Surgical margin involved by ductal carcinoma in situ, extensive
  • Greater than 4 mitoses per high power field
  • Distal surgical margin involved by tumor
  • Surgical bronchial margin involved by tumor
  • Renal pelvis, deep radial hilar surgical margin, involved by tumor
  • Surgical deep margin involved by tumor
  • Mucosal margin involved by adenoma
  • Gerota's fascia surgical margin involved by malignant neoplasm
  • Renal pelvis, deep radial hilar surgical margin, involved by tumour
  • Specimen involvement by macroscopic tumor present
  • Surgical circumferential margin involved by malignant neoplasm (tumor present 0-1 mm from CRM)
  • Surgical distal margin involved by in situ carcinoma/adenoma
  • > 4 mitoses/high power field
  • Small vessel invasion by tumour present
  • Superior lateral surgical margin, involved by tumour
  • Surgical circumferential margin involved by lymphoma
  • Inferior lateral surgical margin involvement by tumour present
  • Surgical proximal margin involved by malignant neoplasm
  • Surgical cystic duct margin involved by in situ carcinoma
  • Surgical margin involved by DCIS, multifocal
  • Renal vein surgical margin involved by malignant neoplasm
  • Urinary bladder, uterine surgical margin, involved by tumour
  • Renal vein surgical margin, involved by tumour
  • Surgical proximal margin involved by in situ carcinoma/adenoma
  • Artefact
  • Cellular changes consistent with Cytomegalovirus
  • Surgical lateral (mucosal/mural) margin involved by in situ carcinoma/adenoma
  • Ureteral surgical margin involved by malignant neoplasm
  • Surgical deep margin involved by malignant neoplasm, focal
  • Microcalcifications present in specimen from breast
  • Proximal renal margin, partial nephrectomy only, involved by tumor
  • 1 or more mitotic figure per mm2
  • Thyroid surgical margin, involved by tumor
  • Urinary bladder, uterine surgical margin, involved by tumor
  • Histological necrosis present after induction chemotherapy
  • Left lateral surgical margin involvement by tumor present
  • Less than or equal to 4 mitoses per high power field
  • Treponema pallidum detected by enzyme-linked immunosorbent assay
  • Distal surgical margin involved by tumour
  • Surgical mucosal margin involved by malignant neoplasm
  • Surgical Gerota's fascial margin involved by malignant neoplasm
  • Surgical margin of renal vessel involved by tumour
  • Artifact
  • Surgical posterior margin involved by malignant neoplasm
  • Treponema pallidum enzyme-linked immunosorbent assay positive
  • Surgical bile duct margin involved by carcinoma in situ
  • Left lateral surgical margin, involvement by tumor present
  • Adrenal surgical margin, involved by tumor
  • Left parametrial surgical margin, involved by tumor
  • Breast tubule formation, majority of tumour greater than 75 percent (score = 1)
  • Deep surgical margin involvement by tumor present
  • Less than 10 mitoses per 10 HPF
  • Surgical margin involved by malignant neoplasm, multifocal
  • Surgical lateral margin involved by malignant neoplasm
  • Specimen involvement by satellite nodule(s) present
  • Surgical lateral margin involved by ductal carcinoma in situ
  • Surgical margin involved by malignant neoplasm
  • Urinary bladder surgical margin, involved by tumour
  • Urinary bladder, deep radial surgical margin, involved by tumor
  • Gross pathology
  • Surgical lateral margin involved by tumour
  • Ureteral surgical margin, involved by tumour
  • Artifact due to crushing
  • Surgical anterior margin involved by malignant neoplasm
  • Morphologic artefact
  • Surgical pancreatic parenchymal margin involved by in situ carcinoma
  • Surgical bronchial margin involved by tumour
  • Perinephric fat surgical margin involved by malignant neoplasm
  • Superior lateral surgical margin involved by tumour
  • Surgical proximal margin involved by in situ carcinoma
  • Matted nodes present in specimen
  • Urinary bladder, vaginal surgical margin, involved by tumour
  • Surgical margin involved by DCIS, unifocal
  • Deep (radial) surgical margin involvement by tumour present (colon/rectum)
  • Left lateral surgical margin involvement by tumour present
  • Greater than 10 mitoses per 10 high power fields (score = 3)
  • Proximal renal margin, partial nephrectomy only, involved by tumour
  • Surgical cystic duct margin involved by malignant neoplasm
  • Surgical mucosal margin involved by in situ carcinoma
  • Deep surgical margin, multifocal, involvement by tumor present
  • Syphilis test finding
  • Urinary bladder, urachal surgical margin, involved by tumor
  • Right lateral surgical margin, involved by tumor
  • Inferior lateral surgical margin, involvement by tumor present
  • Nonsurgical biopsy result abnormal
  • Adrenal surgical margin, involved by tumour
  • Urinary bladder, ureteral surgical margin, involved by tumor
  • Mucosal surgical margin involved by in situ carcinoma
  • Surgical circumferential margin involved by malignant neoplasm
  • Specimen involvement by macroscopic tumour present
  • Renal vein surgical margin, involved by tumor
  • Breast surgical margin involved by tumour
  • Surgical margin involvement by tumour present (breast)
  • Surgical proximal mucosal margin involved by in situ carcinoma
  • Abnormal presence of endometrial cells in specimen
  • Breast tubule formation: Majority of tumor >75% (score = 1)
  • Circumferential resection margin
  • Non-surgical biopsy abnormal
  • Surgical margin involved by ductal carcinoma in situ, multifocal
  • Surgical proximal margin involved by adenoma with low-grade dysplasia
  • Surgical superior margin involved by ductal carcinoma in situ
  • Biopsy of previous biopsy site shows histological change
  • G3-4: Poorly differentiated/undifferentiated
  • Surgical proximal margin involved by lymphoma
  • Distal ureteral surgical margin, involved by tumor
  • Surgical circumferential margin involved by malignant neoplasm (tumour present 0-1 mm from CRM)
  • Surgical deep margin involved by malignant melanoma
  • Surgical margin involved by in situ carcinoma/adenoma
  • Surgical superior margin involved by malignant neoplasm
  • Surgical distal margin involved by tumor
  • Pleura, great vessels surgical margin, involved by tumour
  • 6-10 mitoses per 10 HPF (score = 2)
  • Gerota fascial surgical margin, involved by tumor
  • Colon/rectum, deep (radial) surgical margin involved by tumour
  • Renal capsule surgical margin involved by tumour
  • Surgical margin involved by ductal carcinoma in situ, unifocal
  • Heart surgical margin, involved by tumour
  • Surgical posterolateral (neurovascular bundle) margin involved by malignant neoplasm
  • Ureter, renal pelvis surgical margin, involved by tumour
  • Artifact due to freezing
  • Distal ureteral surgical margin, involved by tumour
  • Lateral surgical margin involvement by tumour present
  • Renal capsular surgical margin, involved by tumor
  • Surgical distal margin involved by lymphoma
  • Gross pathology - abnormality
  • Specimen with abnormal presence of endometrial cells
  • Surgical lateral margin involved by in situ carcinoma
  • Artifact due to smearing
  • Gerota's fascial surgical margin, involved by tumour
  • Superior lateral surgical margin, involved by tumor
  • Surgical parenchymal margin involved by malignant neoplasm
  • Urinary bladder, urethral surgical margin, involved by tumor
  • Deep surgical margin, multifocal, involvement by tumour present
  • Thyroid surgical margin, involved by tumour
  • Surgical distal margin involved by in situ carcinoma
  • Renal pelvis, renal parenchymal surgical margin, involved by tumour
  • Biopsy result abnormal
  • Renal pelvis surgical margin, involved by tumor
  • Surgical margin involved by DCIS, extensive
  • Surgical distal mucosal margin involved by in situ carcinoma
  • Surgical deep margin involved by in situ carcinoma
  • Surgical proximal margin involved by adenoma with high-grade dysplasia
  • Surgical deep margin involved by tumor, focal
  • >10 mitoses per 10 HPF (score = 3)
  • Surgical proximal margin involved by adenoma
  • Surgical margin involved by malignant neoplasm, unifocal
  • Surgical ureteral margin involved by malignant neoplasm
  • Pathology examination findings present
  • Renal pelvis, renal parenchymal surgical margin, involved by tumor
  • Specimen shows excessive autolysis
Frequently Asked Questions
What is the ICD-10 code for abnormal histolog findings in specimens from oth org/tiss?

The ICD-10-CM code for abnormal histolog findings in specimens from oth org/tiss is R89.7. The full clinical description is "Abnormal histological findings in specimens from other organs, systems and tissues". R89.7 is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code R89.7 mean?

ICD-10-CM code R89.7 represents “Abnormal histological findings in specimens from other organs, systems and tissues”. It is classified under Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings and is a billable/specific code that can be used on a claim.

Is R89.7 a billable code?

Yes, R89.7 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is R89.7 in?

R89.7 is in Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings (codes R00-R99).

What codes cannot be used with R89.7?

R89.7 has Excludes1 notes indicating codes that cannot be used together with it, including: abnormal findings on antenatal screening of mother (O28.-); diagnostic abnormal findings classified elsewhere - see Alphabetical Index.

What SNOMED CT codes does R89.7 map to?

R89.7 maps to 163 SNOMED CT concepts: 369787008, 396447006, 396519009, 369788003, 369768002, and 158 more. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for R89.7?

R89.7 is linked to 1 UMLS Concept Unique Identifier: C0478184. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

How does R89.7 relate to ICF functioning codes?

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like abnormal histolog findings in specimens from oth org/tiss affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

What is the ICD-11 equivalent of R89.7?

R89.7 maps to the ICD-11 code: MG67 (Abnormal histological findings in specimens from other organs, systems and tissues).

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.